Accendra Health Inc/Va/ (ACH)BANK OF AMERICA CORP /DE/ now owns 10.8% of ACH as a passive investor 10.8%

10.8%

Stake

8.27M

Shares owned

Stake as of

Sep 30, 2026

Filed

Oct 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 9, 2026Company filing · Form 8-K · Material agreement, Shareholder rightsSigned an important agreement, and changed the rights of its shareholders (and 2 more items)
2. Aug 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On August 10, 2026, Accendra Health, Inc. (the “Company”) announced that Edward A. Pesicka, President, Chief Executive Officer & Director of the Company, notified the board of directors (the “Board”) of the Company of his intention to retire and step down from the Board by the end of 2026, or such earlier time as a successor is appointed.”
3. Aug 10, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
4. Sep 16, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On September 17, 2026, Accendra Health, Inc. (the “Company” or “Accendra Health”) announced that it named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer.”
5. Sep 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 22, 2026, Accendra Health and Mr. Gardner-Smith, the Company’s next President and Chief Executive Officer, mutually agreed to an effective start date of October 5, 2026.”

What came next

1. Oct 6, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On October 6, 2026 Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive…”
2. Oct 7, 20265% stakeBANK OF AMERICA CORP /DE/ reported a passive stake (13G) of 10.8%

How to read SEC Schedule 13G

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Accendra Health Inc/Va/

For Accendra Health Inc/Va/, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACH page.

How this filing works

• Schedule 13D vs 13G

Other disclosures at Accendra Health Inc/Va/

• SEC Form 4Aug 15, 2025
• SEC Form 4Aug 15, 2025
• SEC Form 4Aug 15, 2025
• SEC Form 13F-HRAug 13, 2025
• SEC Form 13F-HRMay 15, 2025
• SEC Form 13F-HRMay 13, 2025

Everything OQRO holds on this company is on its ACH page.